On behalf of subsidiaries-Norley Corporation Inc.: Capital injection to Sharon Glory Limited US$ 42,300,000.

1.Name and nature of the underlying assets (if preferred shares, the terms and conditions of issuance shall also
be indicated, e.g., dividend yield, etc.):
Capital injection by cash
2.Date of occurrence of the event:2024/05/02
3.Amount, unit price, and total monetary amount of the transaction:No par value, US$ 42,300,000
4.Trading counterparty and its relationship with the Company (if the trading counterparty is a natural person and
furthermore is not a related party of the Company, the name of the trading counterparty is not required to
be disclosed):
Sharon Glory Limited, 100% of shares owned by Norley Corporation Inc.
5.Where the trading counterparty is a related party, announcement shall also be made of the reason for choosing
the related party as trading counterparty and the identity of the previous owner, its relationship with the
Company and the trading counterparty, and the previous date and monetary amount of transfer:N/A
6.Where an owner of the underlying assets within the past five years has been a related party of the Company,
the announcement shall also include the date and price of acquisition and disposal by the related party, and
its relationship with the Company at the time of the transaction:N/A
7.Matters related to the current disposal of creditors' rights (including types of collaterals of the disposed
creditor's rights; if creditor's rights over a related party, announcement shall be made of the name of the
related party and the book amount of the creditor's rights, currently being disposed of, over such related
party):N/A
8.Profit or loss from the disposal (not applicable in cases of acquisition of securities) (those with deferral should
provide a table explaining recognition):N/A
9.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the
contract, and other important terms and conditions:
Authorize directors to decide terms of capital injection.
10.The manner of deciding on this transaction (such as invitation to tender, price comparison, or price
negotiation), the reference basis for the decision on price, and the decision-making unit:
The Board of Directors.
11.Net worth per share of the Company's underlying securities acquired or disposed of:N/A
12.Cumulative no.of shares held (including the current transaction), their monetary amount, shareholding
percentage, and status of any restriction of rights (e.g., pledges), as of the present moment:
500 shares, US$42,310,000, 100% of shares, without restricted.
13.Current ratio of securities investment (including the current trade, as listed in article 3 of Regulations
Governing the Acquisition and Disposal of Assets by Public Companies) to the total assets and equity
attributable to owners of the parent as shown in the most recent financial statement and working capital as
shown in the most recent financial statement as of the present:
Ratio of the total asset: 6.52%
Ratio of equity attributable to owners of the parent: 8.67%
Working capital of the parent: NTD 1,476,621 thousand.
14.Broker and broker's fee:N/A
15.Concrete purpose or use of the acquisition or disposal:Purchase a Capesize bulker.
16.Any dissenting opinions of directors to the present transaction:N/A
17.Whether the counterparty of the current transaction is a related party:No.
18.Date of the board of directors resolution:NA
19.Date of ratification by supervisors or approval by the Audit Committee:NA
20.Whether the CPA issued an unreasonable opinion regarding the current transaction:N/A
21.Name of the CPA firm:N/A
22.Name of the CPA:N/A
23.Practice certificate number of the CPA:N/A
24.Whether the transaction involved in change of business model:No.
25.Details on change of business model:N/A
26.Details on transactions with the counterparty for the past year and the expected coming year:N/A
27.Source of funds:N/A
28.Any other matters that need to be specified:None.